Buchumschlag

The role of anticomplement therapy in the management of the kidney allograft

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mehmet Kanbay, Sidar Copur, Zeynep Y. Yilmaz, Dilek Ertoy Baydar, Ilmay Bilge, Caner Susal, Burak Kocak, Alberto Ortiz
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Clinical Transplantation
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

A Case of ABO ‐Incompatible Kidney Transplant in an Infant Patient
von: Cemile Pehlivanoğlu, et al.
Veröffentlicht: (2026)

Successful Use of Haploidentical HSCT in a Child With Schimke Immuno‐Osseous Dysplasia Who Developed PTLD After Kidney Transplantation
von: Cemile Pehlivanoğlu, et al.
Veröffentlicht: (2025)

Protocol biopsy of kidney allograft enables early detection of BK virus nephropathy to preserve kidney allograft function
von: Naoya Iwahara, et al.
Veröffentlicht: (2024)

Extracellular vesicles as potential diagnostic markers for kidney allograft rejection
von: Harit Thongwitokomarn, et al.
Veröffentlicht: (2024)

Impact of hyperparathyroidism on allograft histology and function after kidney transplantation: Rethinking its causal role in graft dysfunction
von: Gabriel Cojuc‐Konigsberg, et al.
Veröffentlicht: (2024)

Mineralocorticoid receptor antagonists in kidney transplantation
von: Mehmet Kanbay, et al.
Veröffentlicht: (2024)

Leflunomide as adjunct therapy for BK viremia management in pediatric kidney transplant recipients
von: Alexandra Aldieri, et al.
Veröffentlicht: (2024)

Optimizing the approach to monitoring allograft inflammation using serial urinary CXCL10/creatinine testing in pediatric kidney transplant recipients
von: Ella Barrett‐Chan, et al.
Veröffentlicht: (2024)

The Exposome Era in Kidney Transplantation: A New Frontier in Graft Outcomes and Precision Medicine
von: Mustafa Guldan, et al.
Veröffentlicht: (2025)

Glucagon and glucagon‐like peptide‐1 dual agonist therapy: A possible future towards fatty kidney disease
von: Mehmet Kanbay, et al.
Veröffentlicht: (2024)

BK polyomavirus DNAemia, allograft rejection, and de novo donor‐specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients
von: Hou‐Xuan Huang, et al.
Veröffentlicht: (2024)

Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors
von: Bernard S. Kadosh, et al.
Veröffentlicht: (2024)

Effect of steroid pulses in severe BK virus allograft nephropathy with extensive interstitial inflammation
von: Julien Carrillo, et al.
Veröffentlicht: (2024)

Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient
von: Jennifer E. Marvin, et al.
Veröffentlicht: (2024)

Adaptation of Pseudomonas aeruginosa to the lung allograft environment in lung transplant patients
von: Köhler, Thilo
Veröffentlicht: (2026)

The First Phylogenetically Confirmed Hemorrhagic Cystitis Outbreak Among Pediatric Hematopoietic Stem Cell Transplant Recipients
von: Tugba Nukte Tezel, et al.
Veröffentlicht: (2025)

Expanding the access to kidney transplantation: Strategies for kidney transplant programs
von: Angie G. Nishio Lucar, et al.
Veröffentlicht: (2024)

How to choose a best kidney for pediatric kidney transplant recipients
von: Asha Moudgil, et al.
Veröffentlicht: (2024)

Prevention and management of infectious and tropical diseases in kidney transplant recipients residing in European outermost and overseas territories
von: Laurène Cachera, et al.
Veröffentlicht: (2024)

Immune monitoring in pediatric kidney transplant
von: Camille Laroche, et al.
Veröffentlicht: (2024)

Five‐year single‐center analysis of cytomegalovirus viremia in kidney transplant recipients and possible implication for novel prophylactic therapy approaches
von: Moritz Trappe, et al.
Veröffentlicht: (2024)

Outcomes after kidney transplant alone in patients with cirrhosis—A case‐control study
von: Rohit R. Nathani, et al.
Veröffentlicht: (2024)

Alemtuzumab induction is associated with decreased hospitalization rates in pediatric kidney transplant: A UNOS data review for safety and outcomes with common induction regimens
von: Emmanuel Aydin‐Ghormoz, et al.
Veröffentlicht: (2024)

Acute Appendicitis in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Single‐Center Experience
von: Mustafa Okumuş, et al.
Veröffentlicht: (2026)

Determinants of hyperparathyroidism in children after kidney transplantation
von: Wendy Glaberson, et al.
Veröffentlicht: (2024)

Adrenal insufficiency in pediatric kidney transplantation recipients
von: Hyunwoong Harry Chae, et al.
Veröffentlicht: (2024)

Maribavir failure in refractory cytomegalovirus infection in a lung transplant patient on extracorporeal membrane oxygenation
von: Christian Kroll, et al.
Veröffentlicht: (2024)

Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient
von: Caroline E. Mullis, et al.
Veröffentlicht: (2024)

Should urinary CXCL10/creatinine be measured for kidney transplantation?
von: Guido Filler, et al.
Veröffentlicht: (2024)

Unrecognized opportunities: The landscape of pediatric kidney‐paired donation in the United States
von: Jennifer Verbesey, et al.
Veröffentlicht: (2024)

Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review
von: Paul M. Kinsella, et al.
Veröffentlicht: (2024)

Survey of Post‐Prophylaxis Delayed‐Onset Cytomegalovirus Management Strategies Among Transplant Providers
von: Lemuel R. Non, et al.
Veröffentlicht: (2024)

Impact of delayed listing after initiating kidney transplant evaluation on transplant outcomes
von: Lisa Ly, et al.
Veröffentlicht: (2024)

Long‐term outcomes of two‐dose alemtuzumab induction in pediatric kidney transplantation
von: Rachel M. Engen, et al.
Veröffentlicht: (2024)

Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients
von: Christie Rampersad, et al.
Veröffentlicht: (2024)

Improving value delivery in living donor kidney transplant through process improvement
von: Jorge Sanchez Garcia, et al.
Veröffentlicht: (2024)

CXCL9 and CXCL10 as biomarkers of kidney graft inflammation across multiple conditions
von: Ilaria Gandolfini, et al.
Veröffentlicht: (2024)

Regulatory T cells in kidney transplant recipients with LIMS1 rs893403 risk genotype
von: Safak Mirioglu, et al.
Veröffentlicht: (2024)

Successful use of eculizumab in immediate ANCA vasculitis recurrence in a pediatric kidney transplant
von: Caitlin G. Peterson, et al.
Veröffentlicht: (2024)

Risk factors and outcomes of bloodstream infection from a urinary source in kidney transplant recipients
von: Emily M. Eichenberger, et al.
Veröffentlicht: (2024)